Forty51 Ventures is a venture capital fund focusing on early-stage investments in health technology, pharmaceuticals, and biotechnology. They provide funding to emerging companies to support growth and success. Notable investments include Allegria Therapeutics and Mysthera Therapeutics. The fund aims to back groundbreaking ideas that can significantly advance healthcare.
